SCHEDULE: Cadian Capital Management Discloses 5.8% Stake in Cryoport

Cadian Capital Management, LP, along with its affiliates, has reported beneficial ownership of approximately 5.8% of Cryoport, Inc.'s common stock as of June 30, 2026.

Summary

• Cadian Capital Management, LP, Cadian Capital Management GP, LLC, and Eric Bannasch (collectively, the 'Reporting Persons') have filed a Schedule 13G, indicating their beneficial ownership of Cryoport, Inc. common stock.
• As of June 30, 2026, the Reporting Persons collectively beneficially owned 2,920,681 shares of Cryoport, Inc. common stock.
• This ownership stake represents approximately 5.8% of the Issuer's outstanding common stock, based on 50,648,491 shares outstanding as of the same date.
• The securities are held by advisory clients of Cadian Capital Management, LP, with the Adviser exercising exclusive voting and investment power.
• Eric Bannasch is identified as the sole managing member of Cadian Capital Management GP, LLC, the general partner of the Adviser.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, indicating a significant but not overwhelming stake by an investment firm. The disclosure itself is routine for Schedule 13G filings.

Positives

• Significant investment by a known investment firm (Cadian Capital Management) suggests confidence in Cryoport's future prospects.
• The filing confirms a substantial ownership stake of 5.8%, indicating active participation or interest from institutional investors.

Negatives

• The filing is a standard disclosure and does not inherently contain negative financial or operational news about Cryoport.

Risks

• As a Schedule 13G filing, it primarily reports ownership and does not detail specific risks related to Cryoport's business operations or financial health.

Future Outlook

This filing is a disclosure of current ownership and does not contain forward-looking statements or guidance from Cryoport, Inc.

Management Comments

• "All securities reported in this Schedule 13G were directly held by Cadian Master Fund L.P. and Cadian Opportunities Master Fund LP (collectively, the 'Advisory Clients'), advisory clients of Cadian Capital Management, LP (the 'Adviser')."
• "Pursuant to Investment Management Agreements between the Advisory Clients and the Adviser, the Adviser exercises exclusive voting and investment power over securities directly held by the Advisory Clients."
• "Eric Bannasch is the sole managing member of Cadian Capital Management GP, LLC."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect..."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. Cadian Capital Management's filing indicates a notable position in Cryoport, a company operating in the specialized logistics and cold chain solutions sector, which has seen increased attention due to advancements in biopharmaceuticals and cell/gene therapies.

Stakeholder Impact

• Shareholders: The filing indicates increased institutional interest, which can sometimes lead to increased stock liquidity and potentially influence stock price, though this filing itself is a routine disclosure.
• Management: The 5.8% stake by Cadian Capital Management may signal a level of scrutiny or potential influence on corporate strategy, though the filing certifies no intent to influence control.

Next Steps

• The Reporting Persons will continue to hold their shares in Cryoport, Inc.
• Future filings will be made if ownership levels change significantly.

Key Dates

Keywords

Cryoport, Cadian Capital Management, Schedule 13G, Beneficial Ownership, Investment, Common Stock, SEC Filing